GSK forms new European consortium to advance Ebola vaccine candidate Print
Friday, 19 December 2014 08:07
British drugmaker GlaxoSmithKline (GSK) and three leading research institutions has formed a new European consortium to help further advance development of a candidate vaccine against Ebola.
read full article